Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.
about
Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover.Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.Cytomegalovirus infection as a cause of cytopenia after chemotherapy for hematological malignancies.Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag.Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children.Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantationLeukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.HLA-identical stem cell transplantation: is there an optimal CD34 cell dose?Management of acute graft-versus-host disease.Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.Concise review: the bone marrow niche as a target of graft versus host disease.Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia.Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis.The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.Platelet transfusion refractoriness after T-cell-replete haploidentical transplantation is associated with inferior clinical outcomes.Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.Microvasculature-directed thrombopoiesis in a 3D in vitro marrow microenvironment.Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation.Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.Haploidentical Stem Cell Transplantation: A Gateway to Infrequent Availability of HLA-Matched Related Donors
P2860
Q33346925-89DBF577-8B2E-47F5-A0EA-BA63B8EB5E73Q33365781-E2294F4D-6304-4C99-8449-D1F7332B0EC4Q33372286-C21322F4-6351-4867-B84F-B10C7C3B719DQ33376399-600AF1E2-8567-4B99-A5E1-FF6F22D2D4C4Q33396929-A74C3503-93BD-458D-8C27-925F7DAA8C34Q33401951-067032CE-1E21-4E35-94EC-C1DB72FCCEB4Q33408944-18F57DC1-0C7E-4B83-B98F-9F743C83ACC9Q33417080-B862F5C8-294E-4ED6-9F5D-C3C0205E08B3Q33422755-7EF59132-726A-4D00-9F88-9A1F30BA6EC4Q33423714-9C5396A1-E963-427A-AFB8-FC342D2E6435Q33441641-486D7371-EBF1-4098-AE19-0575CA527559Q33611550-D67353A4-14C9-4188-B25B-99E330CEEE50Q33684432-1DB39FA6-D6C1-47C4-8156-23EA76A68F03Q35128241-69A68ECF-2C26-4F7D-A867-047A5C4D37B5Q36773002-60E0C750-7D9D-4CDA-9870-FA8D1DCA1E62Q37327622-E4E5A27A-D96A-49B3-999F-CBB8833934B7Q37618790-DAB50617-21B7-4966-94DC-D06CB8160684Q38192559-349C9F6E-5ADE-406C-BEF7-2ECBA5638918Q38474121-80607A12-845A-4010-816A-CFBF65AC5B9EQ38879870-7DD7E975-C738-405B-B1B1-16FDCD327BCBQ40466615-DCDB3388-E973-4873-A877-6E743C939B9DQ44401517-BF875E3F-7EDE-4006-8556-1355B6F1366BQ47575405-2DA5FC39-1E2A-4B51-B6DE-3BC3CA88D68FQ50072576-BA81F372-BAF3-482B-BBB7-7E3EDFC93317Q51749546-7CB294B4-D20F-4ECE-BDAF-BFF99CD5D03EQ52721711-0FAE144D-47A0-4368-8F98-1DC6DC61375CQ52780773-7BC41E14-7A9D-430F-884E-85E0AFBE5F89Q54766326-9C230554-31B5-40A4-BA27-A883FA15EC5EQ57114221-194AC136-7C55-4902-9081-581A3B5BE449
P2860
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Factors influencing haematolog ...... irus infections and cell dose.
@ast
Factors influencing haematolog ...... irus infections and cell dose.
@en
type
label
Factors influencing haematolog ...... irus infections and cell dose.
@ast
Factors influencing haematolog ...... irus infections and cell dose.
@en
prefLabel
Factors influencing haematolog ...... irus infections and cell dose.
@ast
Factors influencing haematolog ...... irus infections and cell dose.
@en
P2093
P2860
P1476
Factors influencing haematolog ...... virus infections and cell dose
@en
P2093
A Bacigalupo
A Dominietto
A M Raiola
F Gualandi
L Casarino
M T van Lint
S Bregante
S Verdiani
T Lamparelli
P2860
P304
P356
10.1046/J.1365-2141.2001.02468.X
P407
P577
2001-01-01T00:00:00Z